CC
PHXM

Cannell & Co’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Cannell & Co’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,600
Closed -$150K – 301
2021
Q3 		$150K Buy
+2,600
New +$150K ﹤0.01% 276